MIGRAINE MATRIX
Glaxo Wellcome Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75530438 |
| Registration Number | 2383943 |
| Mark Drawing Code | 3S11: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Cancellation Code | 2 |
| Attorney Name | Maury M. Tepper, III |
| Law Office Assigned | M50 |
| Employee Name | KEAM, ALEX S |
Timeline
| 1998-08-04 | Application Filed |
| 1998-09-17 | Date of First Use |
| 1999-07-06 | Published for Opposition |
| 2000-09-05 | Trademark Registered |
| 2006-02-21 | Location: TMO LAW OFFICE 111 - DOCKET CLERK |
| 2007-06-09 | Cancelled |
| 2007-06-09 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Wellcome Inc. |
| Address | Five Moore Drive Research Triangle NC 27709 |
| Legal Entity Type | Corporation |
| Legal Entity State | NC |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 261110 | Rectangles divided once into two sections |
| 261121 | Rectangles that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| D10000 | "MIGRAINE" |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1999-02-08 | 1 DOCK D:Assigned to Examiner |
| EXAMINER'S AMENDMENT MAILED | 1999-02-09 | 2 CNEA F:First Action |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1999-02-25 | 3 CNSA P: |
| NOTICE OF PUBLICATION | 1999-06-04 | 4 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1999-07-06 | 5 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 1999-09-28 | 6 NOAM O:Outgoing Correspondence |
| EXTENSION 1 FILED | 1999-11-22 | 7 EXT1 S: |
| USE AMENDMENT FILED | 1999-11-22 | 8 IUAF S: |
| EXTENSION 1 GRANTED | 2000-01-12 | 9 EX1G S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2000-01-12 | 10 SUPC I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2000-01-21 | 11 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 2000-02-17 | 12 CNRT S: |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2000-05-09 | 13 CRFA I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2000-06-14 | 14 CNPR P: |
| REGISTERED-PRINCIPAL REGISTER | 2000-09-05 | 15 R.PR A:Allowance for Publication |
| CASE FILE IN TICRS | 2006-02-17 | 16 CFIT O:Outgoing Correspondence |
| CASE FILE IN TICRS | 2006-02-17 | 17 CFIT O:Outgoing Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2007-06-09 | 18 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MIGRAINE MATRIX 75530438 2383943 Dead/Cancelled |
Glaxo Wellcome Inc. 1998-08-04 |
 MIGRAINE MATRIX 75487577 2383846 Live/Registered |
GLAXOSMITHKLINE LLC 1998-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 